PGR and endometrial cancer: The detailed landscape of M2‐like macrophages must be deciphered with the integration of new technologies, such as multiplexed immunohistochemistry (mIHC) and single‐cell RNA‐seq (scRNA‐seq), for analyzing which M2‐like macrophage subsets regulated PR signaling in breast and endometrial cancer.